PMA device
AeroPace® System
Lungpacer Medical USA, Inc. · Transvenous Temporary Phrenic Nerve Stimulator (SDL, Class III) · First FDA decision Dec 4, 2024, newest Jun 22, 2026Respiratory failure and ventilation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
Breakthrough-designated
Device trials
4
Naming "AeroPace"
MAUDE reports
0
Brand "AeroPace", since 2015
PubMed studies
0
Mentioning "AeroPace"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing AeroPace® System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- AeroPace® SystemPMA supplement
P240012-S007 · Decided Jun 22, 2026 · 27 days after receipt · Normal 180 Day Track No User Fee
Device type: Transvenous temporary phrenic nerve stimulator (SDL) · Anesthesiology & Respiratory
- AeroPace® SystemPMA supplement
P240012-S005 · Decided Feb 20, 2026 · 28 days after receipt · Normal 180 Day Track No User Fee
Device type: Transvenous temporary phrenic nerve stimulator (SDL) · Anesthesiology & Respiratory
- AeroPace® SystemPMA supplement
P240012-S001 · Decided Jan 30, 2025 · 30 days after receipt · Normal 180 Day Track No User Fee
Device type: Transvenous temporary phrenic nerve stimulator (SDL) · Anesthesiology & Respiratory
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "AeroPace", any status and sponsor, newest update first.
- A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical VentilationPivotal-lookingTerminated
Lungpacer Medical Inc.Not on our public-company list
NCT03783884 · 223 participants · Start Jun 14, 2019 · Primary completion Dec 28, 2022
Device: Lungpacer Diaphragm Pacing Therapy · For: Ventilator Induced Diaphragm Dysfunction (VIDD)
Sites: Stanford, California; Aurora, Colorado; Gainesville, Florida · 33 sites in all
Lungpacer Medical Inc.Not on our public-company list
NCT07477054 · 120 participants (planned) · Start Oct 31, 2026 · Primary completion Aug 31, 2028
Device: Lungpacer Diaphragm Pacing Therapy · For: Ventilator Induced Diaphragm Dysfunction
Sites: San Francisco, California
Fraser HealthAcademic, hospital or other
NCT07505589 · 3 participants · Start Jan 31, 2024 · Primary completion Dec 1, 2025
Device: Lungpacer AeroPace catheter and device · For: Lung; Organ Donation; Mechanical Ventilation
Sites: New Westminster, Canada
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "AeroPace", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SDL
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "AeroPace"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.